Illustrative image – not actual.MSD India, a drug company and fully-owned subsidiary of US based Merck & Co, plans to set up a research and development (R&D) centre in India in JV with UK based Wellcome Laboratories.
The centre - MSD Wellcome Trust Hilleman Laboratories - will be a 50:50 JV and come up with a total investment of $130 million (approx Rs 586 crore). Of this, MSD is expected to pump in $65 million (approx Rs 292.5 crore). The centre will develop affordable vaccines for the developing countries.
